wound healing and/or the body’s ability to deal with infection. Symptoms of infection may be masked or atypical. Careful consideration should be given as to the desirability of administration to patients with systemic infections, if specific anti-infective is neither possible nor instigated. In the presence of viral infection, corticosteroids may worsen or hasten the progress of the disease. Gastrointestinal ulceration has been reported in animals treated with corticosteroids.
4.7 Pregnancy and lactation
Prednisolone is not recommended for use in pregnant animals. Administration of corticosteroids in early pregnancy is known to cause foetal abnormalities in laboratory animals. Administration in late pregnancy may cause early parturition.
4.8 Interactions
Gastrointestinal ulceration may be exacerbated by corticosteroids in patients given non-steroidal anti-inflammatory drugs.
Our Standard Delivery - £6.75
Royal Mail Tracked 24 (Signed For)
- Next business day service
- Compensation cover up to £100
- Signature on delivery
Any orders placed after close of business on Thursday will not be delivered until Tuesday
Our Express Delivery - £10.45
Royal Mail Special Delivery Guaranteed by 1pm
- Next business day service
- Insured up to £500
- Signature on delivery
Please note that all chilled deliveries must be sent on an Express service.
Chilled orders placed after close of business on Wednesday will not be despatched until Monday
You must be logged in to write review
Category
|
POM-V
|
Temperature
|
Ambient
|
MA/VM/EU No:
|
04409/4003
|
Species
|
|
VMD Link
|
https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_138872.PDF
|
NOAH Link
|
|
Dosage
|
4.9 Posology
Generally 0.1-2.0mg/Kg/day. For treatment of tumours 20mg/ m2 of body surface each other day to 60mg/ m2 of body surface/day. By oral administration only.
4.10 Overdose
There is no specific treatment for overdose. Treatment will be largely symptomatic. Gross over dosage might result in immunosuppression. Accompanying cover of antibiotics treatment should be restricted to responses to specific signs and symptoms. Serum electrolytes should be monitored.
|
Withdrawals
|
|